Over the past year there were no insider purchases at Axogen, Inc.. 12 insiders sold roughly $19.3 million instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
253 investment managers listed AXGN in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | TYNDALL JOSEPH A. | Director | Sell | 3,500 | $49.70 | $174K | SEC |
| Aug 12, 2026 | Began Marc A | Executive Officer | Sell | 67,500 | $47.35 | $3.2M | SEC |
| Aug 12, 2026 | Wendell Amy McBride | Director | Sell | 13,353 | $48.42 | $647K | SEC |
| Aug 11, 2026 | Weiler Kathy Johnson | Director | Sell | 14,150 | $45.30 | $641K | SEC |
| May 12, 2026 | Wendell Amy McBride | Director | Sell | 1,647 | $42.60 | $70K | SEC |
| May 8, 2026 | JOHNSON JOHN | Director | Sell | 11,050 | $43.26 | $478K | SEC |
| May 8, 2026 | Weiler Kathy Johnson | Director | Sell | 16,344 | $44.09 | $721K | SEC |
| May 8, 2026 | Kemp Jens | Executive Officer | Sell | 4,000 | $43.44 | $174K | SEC |
| May 8, 2026 | Hartley Lindsey Marie | CFO | Sell | 478 | $43.67 | $21K | SEC |
| May 8, 2026 | Hartley Lindsey Marie | CFO | Sell | 573 | $43.67 | $25K | SEC |
| May 8, 2026 | Quackenbush Doris | Officer | Sell | 3,878 | $43.51 | $169K | SEC |
| Mar 18, 2026 | DeVinney Erick Wayne | Executive Officer | Sell | 5,221 | $32.84 | $171K | SEC |
| Dec 17, 2025 | Wendell Amy McBride | Director | Sell | 20,436 | $29.31 | $599K | SEC |
| Dec 17, 2025 | Weiler Kathy Johnson | Director | Sell | 21,825 | $29.55 | $645K | SEC |
| Dec 17, 2025 | Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442K | SEC |
In the last 12 months Axogen, Inc. insiders made open-market purchases worth about $0 and sales worth about $19.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in AXGN was filed on 2026-09-04.
253 investment managers reported holding AXGN in SEC Form 13F filings for Q2 2026.
No congressional trades in AXGN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).